Literature DB >> 23541427

Placental mesenchymal stem cells: a unique source for cellular cardiomyoplasty.

Georges Makhoul1, Ray C J Chiu, Renzo Cecere.   

Abstract

In coronary heart disease, the use of stem cells for regeneration purposes has been broadly studied. Whereas bone marrow mesenchymal stem cells remain the most extensively investigated, other cell sources have been reported. Here we discuss and compare the characteristics of placenta-derived mesenchymal stem cells as a novel alternative cell source for cellular cardiomyoplasty. These cells are isolated from the human term placenta, which is normally discarded post partum. With their lack of ethical conflicts and young age, the readily available placenta-derived mesenchymal stem cells could be more suitable for myocardial regenerative therapy.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 23541427     DOI： 10.1016/j.athoracsur.2012.11.053

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  8 in total

Review 1.  Placental mesenchymal stromal cells as an alternative tool for therapeutic angiogenesis.

Authors:  Suja Ann Mathew; Charuta Naik; Paul A Cahill; Ramesh R Bhonde
Journal:  Cell Mol Life Sci       Date:  2019-08-29       Impact factor: 9.261

2.  Early gestation chorionic villi-derived stromal cells for fetal tissue engineering.

Authors:  Lee Lankford; Taryn Selby; James Becker; Volodymyr Ryzhuk; Connor Long; Diana Farmer; Aijun Wang
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

3.  Human placental mesenchymal stem cells ameliorate liver fibrosis in mice by upregulation of Caveolin1 in hepatic stellate cells.

Authors:  Yunqi Yao; Zhemin Xia; Fuyi Cheng; Qingyuan Jang; Jiao He; Cheng Pan; Lin Zhang; Yixin Ye; Yuan Wang; Shuang Chen; Dongsheng Su; Xiaolan Su; Lin Cheng; Gang Shi; Lei Dai; Hongxin Deng
Journal:  Stem Cell Res Ther       Date:  2021-05-20       Impact factor: 6.832

Review 4.  Significance of Placental Mesenchymal Stem Cell in Placenta Development and Implications for Preeclampsia.

Authors:  Yang Zhang; Yanqi Zhong; Li Zou; Xiaoxia Liu
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

Review 5.  Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy.

Authors:  Seahyoung Lee; Eunhyun Choi; Min-Ji Cha; Ki-Chul Hwang
Journal:  Oxid Med Cell Longev       Date:  2015-02-02       Impact factor: 6.543

6.  Adipogenic placenta-derived mesenchymal stem cells are not lineage restricted by withdrawing extrinsic factors: developing a novel visual angle in stem cell biology.

Authors:  C Hu; H Cao; X Pan; J Li; J He; Q Pan; J Xin; X Yu; J Li; Y Wang; D Zhu; L Li
Journal:  Cell Death Dis       Date:  2016-03-17       Impact factor: 8.469

7.  Human placental mesenchymal stromal cells are ciliated and their ciliation is compromised in preeclampsia.

Authors:  Andreas Ritter; Juping Yuan; Sophia Indira Romberg; Nina-Naomi Kreis; Alexandra Friemel; Susanne Roth; Alice Steglich Souto; Samira Catharina Hoock; Kyra Fischer; Thorsten Nowak; Christine Solbach; Frank Louwen
Journal:  BMC Med       Date:  2022-01-27       Impact factor: 8.775

Review 8.  Allogenic Use of Human Placenta-Derived Stromal Cells as a Highly Active Subtype of Mesenchymal Stromal Cells for Cell-Based Therapies.

Authors:  Raphael Gorodetsky; Wilhelm K Aicher
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.